Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NAFLD/MAFLD”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Not applicableLooking for participantsNCT07658755
What this trial is testing

Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseLiver FibrosisNon-alcoholic Fatty Liver Disease NAFLD+3 more
Hospital General Universitario Gregorio Marañon 3,000
Not applicableLooking for participantsNCT07068191
What this trial is testing

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more
Phenomen Pharma 90
Testing effectiveness (Phase 2)Looking for participantsNCT05984745
What this trial is testing

Effect of CoQ10 on the Outcome of MAFLD Patients

Who this might be right for
Fatty LiverNAFLD
Ain Shams University 60
Not applicableUnknownNCT05239260
What this trial is testing

Impact of Fluid Status on Liver Elastography and T1-mapping Results in Patients Undergoing CMR.

Who this might be right for
NAFLD/MAFLDLiver FibrosisCMR
Medical University of Vienna 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07637006
What this trial is testing

Linzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty Liver

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Hong Kong Baptist University 180
Not applicableEnrolling By InvitationNCT05956379
What this trial is testing

Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.

Who this might be right for
Chronic Hepatitis BNon-alcoholic Fatty Liver Disease
National Taiwan University Hospital 100
Not applicableNot Yet RecruitingNCT06097338
What this trial is testing

Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFF

Who this might be right for
Fatty Liver Disease, Nonalcoholic
Qianfoshan Hospital 200
Post-approval studies (Phase 4)Study completedNCT05474560
What this trial is testing

Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseHyperuricemia
Ain Shams University 90
Not applicableUnknownNCT05525884
What this trial is testing

Mechanism of Serum PRL in the Development of MAFLD

Who this might be right for
Type2 DiabetesFatty Liver, NonalcoholicLiver Fibrosis
Shen Qu 1,000
Not applicableUnknownNCT05421572
What this trial is testing

Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Fatty Liver Disease
Beijing Tsinghua Chang Gung Hospital 2,000
Not applicableNot Yet RecruitingNCT06563921
What this trial is testing

RE and Probiotics in MAFLD/NAFLD

Who this might be right for
NASHNAFLDMAFLD
Nicolaus Copernicus University 180
Testing effectiveness (Phase 2)Study completedNCT04929483
What this trial is testing

Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
89bio, Inc. 222
Not applicableEnrolling By InvitationNCT07564947
What this trial is testing

Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)

Who this might be right for
MAFLDFatty LiverFatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD+4 more
University of Agriculture, Peshawar 40
Not applicableStudy completedNCT06344364
What this trial is testing

Digital Pathology and AI for Liver Outcomes in MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
PharmaNest, Inc 1,241
Not applicableUnknownNCT05880316
What this trial is testing

Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting

Who this might be right for
Fatty Liver Disease
Universiti Kebangsaan Malaysia Medical Centre 100
Testing effectiveness (Phase 2)UnknownNCT05966025
What this trial is testing

Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Fatty Liver DiseaseFatty Liver
October 6 University 60
Not applicableLooking for participantsNCT06717828
What this trial is testing

The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Fujian Provincial Hospital 250
Not applicableNot Yet RecruitingNCT07570810
What this trial is testing

Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM

Who this might be right for
Type 2 DiabetesObesityNon-alcoholic Fatty Liver Disease
Shanghai Jiao Tong University School of Medicine 30
Not applicableUnknownNCT06503068
What this trial is testing

Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian Patients

Who this might be right for
NAFLD
Tanta University 500
Next Page